Literature DB >> 9465805

Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study.

W T Creasman1, R J Zaino, F J Major, P J DiSaia, K D Hatch, H D Homesley.   

Abstract

OBJECTIVE: Our purpose was to evaluate the risk factors and prognosis in patients with stage IA squamous cell carcinoma of the cervix and 3 to 5 mm of invasion. STUDY
DESIGN: From 1981 to 1984 the Gynecologic Oncology Group conducted a prospective clinicopathologic study of patients with stage I carcinoma of the cervix. A selective study group that was previously defined and reported included patients with squamous cell carcinoma of the cervix who were treated with radical hysterectomy and pelvic lymphadenectomy and who had disease confined to the uterus, with or without microscopically positive lymph nodes.
RESULTS: One hundred eighty-eight patients had invasion of 3, 4, or 5 mm as determined by central pathology review. Patients who satisfied the 3 to 5 mm invasion definition of the current stage IA2 classification of the International Federation of Gynecology and Obstetrics (1995) are the subject of this report.
CONCLUSIONS: Patients with stage IA2 carcinoma of the cervix who have 3 to 5 mm of invasion present on conization with no invasion in the hysterectomy specimen are at very low risk for lymph node metastases, recurrences, or death caused by cancer.

Entities:  

Mesh:

Year:  1998        PMID: 9465805     DOI: 10.1016/s0002-9378(98)70628-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

Review 1.  Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer.

Authors:  Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

Review 2.  Perspective for prophylaxis and treatment of cervical cancer: an immunological approach.

Authors:  Marjorie Jenkins; Maurizio Chiriva-Internati; Leonardo Mirandola; Catherine Tonroy; Sean S Tedjarati; Nicole Davis; Nicholas D'Cunha; Lukman Tijani; Fred Hardwick; Diane Nguyen; W Martin Kast; Everardo Cobos
Journal:  Int Rev Immunol       Date:  2012-02       Impact factor: 5.311

3.  The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma.

Authors:  O Ozsarlak; W Tjalma; E Schepens; B Corthouts; B Op de Beeck; E Van Marck; P M Parizel; A M De Schepper
Journal:  Eur Radiol       Date:  2003-06-12       Impact factor: 5.315

4.  Prediction of 5-year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods.

Authors:  Bogdan Obrzut; Maciej Kusy; Andrzej Semczuk; Marzanna Obrzut; Jacek Kluska
Journal:  BMC Cancer       Date:  2017-12-12       Impact factor: 4.430

5.  Prediction of 10-year Overall Survival in Patients with Operable Cervical Cancer using a Probabilistic Neural Network.

Authors:  Bogdan Obrzut; Maciej Kusy; Andrzej Semczuk; Marzanna Obrzut; Jacek Kluska
Journal:  J Cancer       Date:  2019-07-10       Impact factor: 4.207

Review 6.  Surgical treatment of stage IA2 cervical cancer.

Authors:  Fani Kokka; Andrew Bryant; Elly Brockbank; Arjun Jeyarajah
Journal:  Cochrane Database Syst Rev       Date:  2014-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.